NexImmune: Jumps in Nasdaq debut

Neximmune

12/02/2021 17:04

** Shares of biotech co NexImmune Inc  NEXI.O  jump more
than 35% to $23.01 after their stock market debut 
    ** At the opening price, co had a market cap of $482.34 mln
    ** NEXI's IPO was priced at $17 per share
    ** Co offered 6.47 mln shares in IPO, raising about $110 mln
    ** NEXI is a clinical stage biotech firm that develops
treatments which help produce immune system responses that mimic
natural biology
    ** Barclays, Cantor, Raymond James and Allen & Company LLC
were the joint book-running managers for the offering 

 (Reporting by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com))